News
FDA rushed out agency-wide AI tool—it’s not going well
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't connected to the Internet or the FDA's internal system, and has problems uploading documents and allowing users to submit questions.
FDA's new AI tools struggle with simple tasks
The Food and Drug Administration has introduced a new AI tool that could expedite the review and approval process for medical devices but it is said to be struggling with simple tasks. NBC News' Dr. Kavita Patel explains the impact AI can have in the medical field.
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
Alex Ratner, CEO of Snorkel AI, remembers a time when data labeling —the grueling task of adding context to swathes of raw ...
It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
California and three other states have called on the FDA to ease new restrictions on the abortion pill mifepristone, which ...
This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback